Nand Singh

A Phase 1 Pharmacokinetic Drug Interaction Study of Belumosudil Coadministered With CYP3A4 Inhibitors and Inducers and Proton Pump Inhibitors

O. Schueller, Ashley Willson, Nand Singh, 2022, Clinical pharmacology in drug development.

Absolute Bioavailability, Mass Balance, and Metabolic Profiling Assessment of [14C]‐Belumosudil in Healthy Men: A Phase 1, Open‐Label, 2‐Part Study

O. Schueller, M. Sanghvi, I. Shaw, 2022, Clinical pharmacology in drug development.

Absorption, metabolism and excretion of opicapone in human healthy volunteers

L. Kiss, P. Soares-da-Silva, M. Bonifácio, 2022, British journal of clinical pharmacology.

Absence of Pharmacokinetic Interactions between the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib and Methotrexate

L. Chinn, Nand Singh, H. Winter, 2019, The Journal of Pharmacology and Experimental Therapeutics.

Two‐Part Phase 1 Study to Evaluate the Taste Profile of Novel Belumosudil Oral Suspensions and Assess the Relative Bioavailability and Food Effect of the Selected Belumosudil Oral Suspension Compared With Oral Tablet Reference in Healthy Male Participants

Ashley Willson, Nand Singh, L. Lohmer, 2024, Clinical pharmacology in drug development.